← Evidence map

ReviewFrontiers in immunology2025

T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40510347